OAM
TMO icon

Oppenheimer Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Oppenheimer Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.2M Buy
65,576
+4,306
+7% +$2.34M 0.37% 62
2025
Q4 		$35.5M Buy
61,270
+1,191
+2% +$674K 0.44% 53
2025
Q3 		$29.1M Sell
60,079
-34,081
-36% -$15.9M 0.32% 69
2025
Q2 		$38.2M Buy
94,160
+4,816
+5% +$2.01M 0.44% 44
2025
Q1 		$44.5M Buy
89,344
+4,605
+5% +$2.49M 0.55% 33
2024
Q4 		$44.1M Sell
84,739
-5,604
-6% -$3.08M 0.54% 33
2024
Q3 		$55.9M Buy
90,343
+7,427
+9% +$4.4M 0.67% 22
2024
Q2 		$45.9M Buy
82,916
+17,913
+28% +$10.3M 0.59% 29
2024
Q1 		$37.8M Buy
65,003
+4,020
+7% +$2.26M 0.55% 38
2023
Q4 		$32.4M Sell
60,983
-1,808
-3% -$875K 0.45% 44
2023
Q3 		$31.8M Buy
62,791
+2,876
+5% +$1.53M 0.49% 41
2023
Q2 		$31.3M Sell
59,915
-63
-0.1% -$34K 0.46% 42
2023
Q1 		$34.6M Buy
59,978
+4,740
+9% +$2.67M 0.53% 40
2022
Q4 		$30.4M Buy
55,238
+27,346
+98% +$14.5M 0.49% 42
2022
Q3 		$14.1M Buy
27,892
+2,653
+11% +$1.48M 0.25% 92
2022
Q2 		$13.7M Sell
25,239
-99
-0.4% -$54.5K 0.23% 105
2022
Q1 		$15M Sell
25,338
-8,805
-26% -$5.06M 0.21% 117
2021
Q4 		$22.8M Sell
34,143
-75
-0.2% -$46.8K 0.3% 75
2021
Q3 		$19.6M Buy
34,218
+579
+2% +$318K 0.28% 81
2021
Q2 		$17M Buy
33,639
+244
+0.7% +$115K 0.24% 94
2021
Q1 		$15.2M Sell
33,395
-776
-2% -$370K 0.24% 99
2020
Q4 		$15.9M Sell
34,171
-2,162
-6% -$1.01M 0.27% 88
2020
Q3 		$16M Buy
36,333
+1,718
+5% +$710K 0.31% 73
2020
Q2 		$12.5M Buy
34,615
+1,806
+6% +$605K 0.26% 96
2020
Q1 		$9.3M Sell
32,809
-841
-2% -$265K 0.23% 111
2019
Q4 		$10.9M Buy
33,650
+402
+1% +$122K 0.23% 104
2019
Q3 		$9.68M Sell
33,248
-815
-2% -$233K 0.22% 112
2019
Q2 		$10M Sell
34,063
-1,704
-5% -$469K 0.22% 103
2019
Q1 		$9.79M Sell
35,767
-7,286
-17% -$1.81M 0.22% 111
2018
Q4 		$9.63M Sell
43,053
-2,483
-5% -$583K 0.24% 101
2018
Q3 		$11.1M Sell
45,536
-739
-2% -$170K 0.25% 97
2018
Q2 		$9.59M Buy
46,275
+2,549
+6% +$541K 0.23% 105
2018
Q1 		$9.03M Sell
43,726
-2,688
-6% -$564K 0.23% 111
2017
Q4 		$8.78M Hold
46,414
– – 0.23% 111
2017
Q3 		$8.78M Sell
46,414
-7,344
-14% -$1.33M 0.23% 113
2017
Q2 		$9.38M Sell
53,758
-3,852
-7% -$647K 0.26% 100
2017
Q1 		$8.85M Buy
+57,610
New +$8.81M 0.25% 97

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Oppenheimer Asset Management's TMO Position: Q1 2026 in Review

Oppenheimer Asset Management increased its Thermo Fisher Scientific (TMO) stake by 7% in Q1 2026, buying an estimated $2.34M and bringing the position to 65,576 shares worth $32.2M. The position accounts for 0.37% of the portfolio, ranked #62.

Oppenheimer Asset Management first reported a position in TMO in Q1 2017 and has held it in 37 quarters since. The position peaked at $55.9M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Oppenheimer Asset Management held 65,576 shares of Thermo Fisher Scientific worth $32.2M as of Q1 2026.
  • Oppenheimer Asset Management bought 4,306 Thermo Fisher Scientific shares in Q1 2026, an estimated $2.34M.
  • Thermo Fisher Scientific made up 0.37% of Oppenheimer Asset Management's portfolio in Q1 2026, its #62 holding.
  • Oppenheimer Asset Management first reported a position in Thermo Fisher Scientific in Q1 2017 and has held it in 37 quarters since.
  • Oppenheimer Asset Management's Thermo Fisher Scientific position peaked at $55.9M in Q3 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Oppenheimer Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.